Btw, the concern about epitope cross reactivity with the widely expressed Claudin 9 mentioned in the article is real. There was an @iScience_CP paper last year on developing highly specific anti-Claudin 6 antibodies that do not cross react. https://t.co/EEmS0AHBLN
Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2022 – Oct 2024Where it's discussed
-
News60 articles
-
X / Twitter6 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions reflect a moderate level of interest and agreement, exemplified by comments referencing previous related papers and emphasizing the relevance of the study's findings, such as concerns about epitope specificity and its therapeutic potential. The tone indicates respect for the research's significance, but the engagement remains relatively surface-level.
Most discussions acknowledge the importance of the research, especially the concern about cross-reactivity with Claudin 9, indicating general approval and recognition of the study's significance.
Participants show moderate curiosity, with some referencing previous related research and urging others to read the full article, but few delve deeply into methodological details.
The interactions are somewhat superficial, mainly repeated affirmations or references to related work, rather than in-depth conversations or critiques.
The discussions highlight the potential implications for targeted cancer therapies, suggesting the research could influence future treatment strategies, but without detailed debate.
Abstract in brief
- The study focuses on developing highly specific monoclonal antibodies (MAbs) against the cancer-associated protein Claudin 6 (CLDN6), which is similar to the closely related protein CLDN9, making targeted therapy challenging.
- Researchers successfully isolated rare MAbs that bind tightly to CLDN6 with minimal cross-reactivity to CLDN9 by identifying unique epitopes at the amino acid level, particularly a single contact point involving the carbon atom on CLDN6 residue Q156.
- The structural analysis revealed that these MAbs distinguish CLDN6 from CLDN9 through steric hindrance at this key atomic contact, offering a promising approach for more precise cancer therapies targeting CLDN6.]
Top posts
Most liked on X and BlueskyRead the full research article here. $CNTX https://t.co/cUb9V9ciCU
RT @Aiims1742: Btw, the concern about epitope cross reactivity with the widely expressed Claudin 9 mentioned in the article is real. There…
Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point https://t.co/SAyjNm2EGC https://t.co/cMtDIwoipX
RT @Aiims1742: Btw, the concern about epitope cross reactivity with the widely expressed Claudin 9 mentioned in the article is real. There…
Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point https://t.co/O3vY3ObMgQ
All mentions
Molecular Dynamics of Claudin 6 Antigen Antibody Complex Analysis
This video explores molecular modeling and dynamic simulations of the Claudin 6 antigen-antibody complex. Using advanced software like VMD and NAMD, it demonstrates simulating large biological structures and discusses…
Molecular Dynamics Simulation of Claudin 6 Antigen Antibody Complex for Cancer Therapy
This video demonstrates molecular dynamic simulations of the Claudin 6 antigen antibody complex, utilizing computational chemistry methods, protein structure prediction, and GPU-accelerated platforms for insights into…
Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point https://t.co/O3vY3ObMgQ
RT @Aiims1742: Btw, the concern about epitope cross reactivity with the widely expressed Claudin 9 mentioned in the article is real. There…
RT @Aiims1742: Btw, the concern about epitope cross reactivity with the widely expressed Claudin 9 mentioned in the article is real. There…
Btw, the concern about epitope cross reactivity with the widely expressed Claudin 9 mentioned in the article is real. There was an @iScience_CP paper last year on developing highly specific anti-Claudin 6 antibodies that do not cross react. https://t.co/EEmS0AHBLN
Read the full research article here. $CNTX https://t.co/cUb9V9ciCU
Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point https://t.co/SAyjNm2EGC https://t.co/cMtDIwoipX